Purchase Order 15B10926P00000006
- Not listed
- McKesson Corporation, a leading pharmaceutical distribution and medical supply provider headquartered in Irving, Texas, received a $17,953.48 firm fixed-price purchase order from the Federal Medical Center Lexington on December 1, 2025, for multiple medication shipments to be delivered through December 31, 2025. This non-competitive contract award addresses the medical center's pharmaceutical supply needs for the final month of fiscal year 2026. The award was made without a set-aside...
- The U.S. Federal Medical Center Lexington, a civilian facility within the Department of Justice, awarded a delivery order to McKesson Corporation for routine wholesale medication purchases valued at $610.7K. This Firm Fixed Price contract covers multiple invoices for controlled and non-controlled pharmaceutical shipments received during the first quarter of fiscal year 2025 (September 1-30, 2025). The contract was awarded without a set-aside designation, reflecting McKesson's status as a large...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $480,643.73 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from October 1, 2023 through November 20, 2023. Mckesson will supply the Bureau of Prisons facility in Lexington, Kentucky with pharmaceutical products...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $287,645.47 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from November 1, 2022 through December 9, 2022. Mckesson will supply pharmaceutical products to the Federal Medical Center Lexington facility located in...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded McKesson Corporation, doing business as McKesson Drug Company, a $167,305.48 firm fixed price delivery order contract to provide routine wholesale non-controlled and controlled substance medication purchases from October through December 2023. McKesson, a wholly owned subsidiary of McKesson Corporation, will fulfill multiple invoices for medication shipments from its location in Irving, Texas to the Bureau of...
- McKesson Corporation received a purchase order award from the Federal Medical Center Lexington on September 1, 2025, for multiple medication shipments to be used during the first quarter of fiscal year 2025 (September 1-30, 2025). The contract is a firm fixed-price purchase order with a ceiling value of $12,790.94 and no set-aside designation. Performance will be completed at McKesson's Irving, Texas location, with a completion date of September 30, 2025. This award represents a continuation...
- McKesson Corporation received a delivery order award on December 1, 2025, for the supply of non-controlled and controlled substances to Federal Medical Center Lexington, a civilian facility operated under the Department of Justice. The contract has a firm fixed-price structure with a ceiling value of $574,207.77 and is scheduled for completion by December 31, 2025. No set-aside designation was applied to this competitive award. McKesson will perform the delivery from its facility in Irving,...
- McKesson Corporation was awarded a delivery order valued at $543,762.08 by the Federal Medical Center Lexington for routine wholesale medication purchases covering non-controlled and controlled substances. The award, effective November 1, 2025, with an ultimate completion date of November 30, 2025, represents multiple invoices for medication shipments received during the first month of fiscal year 2025. The contract was awarded on a firm fixed-price basis with no set-aside designation and...
- The Department of Justice Bureau of Prisons Federal Medical Center in Lexington awarded McKesson Corporation a $17,956.85 purchase order to supply medications. Under the terms of the non-contract award, McKesson will ship medications to the correctional facility in Irving, Texas between September 1st and October 23rd, 2023. As the largest pharmaceutical distributor in the U.S., McKesson will fulfill this requirement from their distribution center in Irving. No subcontractors or set-aside...
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a firm fixed price purchase order by the Federal Medical Center Lexington (a civilian agency under the Department of Justice) on October 1, 2025. The contract, valued at $9,851.86, covers multiple invoices for medication shipments to be used during October 1-31, 2025, with a completion date of October 31, 2025. The award was made without a set-aside...
McKesson Corporation received a $19.37K firm fixed-price purchase order from the Federal Medical Center Lexington (a civilian facility under the Department of Justice) on November 1, 2025, for multiple medication shipments to be delivered through November 30, 2025. The order, classified as a non-contract account transaction, covers pharmaceutical supplies for the facility's operations during the specified period. No small business set-aside was utilized for this procurement, and performance will be completed at McKesson's facility in Irving, Texas. Federal Medical Center Lexington, operated by the Bureau of Prisons, regularly procures controlled and non-controlled medications through McKesson, a major pharmaceutical distributor serving the federal corrections system. McKesson's extensive federal contracting experience with the Bureau of Prisons and other agencies makes it a primary source for medical supply procurement across correctional facilities. This purchase order represents routine pharmaceutical replenishment for the facility's ongoing healthcare operations and is consistent with McKesson's established role as a key provider of medications and medical products to federal correctional institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 11/24/25 |